Up Next:
Thursday, September 26, 12pm EST
Presented by: Dr. Mert Aral, Chief Medical Office at Huma
Ben Irving, VP of AI at Huma
Register
Earlier this year, Huma launched the HumaMG app to help Myasthenia Gravis (MG) patients optimize their treatment and maintain symptom control. In our ongoing efforts, we invite you to discover the latest AI innovations poised to transform MG patient care by enhancing our understanding on impact of medication, improving symptom identification, and assisting clinicians in monitoring progress to efficiently optimize treatment.
Join Dr. Mert Aral, Chief Medical Office at Huma, and Ben Irving, VP of AI at Huma. Mert leads initiatives focused on patient care, safety, and improved outcomes through clinically-led product development. As a key executive, he drives company strategy in SaMD, remote monitoring, and digital clinical trials. Previously, he worked as a clinician for seven years at prestigious centers in Boston, Chicago, Cambridge, and London. Ben has worked for over 10 years in the AI and healthcare space developing patient and disease monitoring solutions that have been deployed for clinical monitoring of patients, clinical studies and large scale screening.